Vasculead Inc. is a pharmaceutical startup company initiated from Osaka University, established on May 1, 2017.
Blood vessels in our body have a fundamental role in homeostasis. The research on the human vascular system has shown its strong involvement in many diseases affecting human life.
In the past, the “Vascular Inhibition concept” based treatment which inhibits neovascular formation has been used to treat cancer and other diseases. Recently however, more research has been focused on “Vascular Promotion Concept” based treatment which induces vascular network formation and maturation of vascular tissues. In the clinical studies, the “Vascular Promotion Concept” based treatments have shown to be highly effective in the treatment of various cancers.
Professor Nobuyuki Takakura at Research Institute for Microbial Disease, Osaka University, is a leading expert in vascular research in Japan and a world leader in this “Vascular Promotion Concept”. Our company has teamed up with Professor Takakura as a business venture for the development and the promotion of the drug manufacturing based on his “Vascular Promotion Concept” research to become an industry leader in creating a cure for cancer and other diseases.